Koers Kadimastem Ltd TEL AVIV STOCK EXCHANGE
Aandelen
KDST
IL0011284614
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 24,87 mln. 93,66 mln. 23,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -22 mln. -82,86 mln. -20,57 mln. | Nettowinst (verlies) 2023 | -12 mln. -45,19 mln. -11,22 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 739K 2,78 mln. 691K | Nettoschuld 2023 | 2,17 mln. 8,17 mln. 2,03 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,76
x | K/w-verhouding 2023 |
-2,12
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 39,92% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Asaf Shiloni
CEO | Chief Executive Officer | 54 | 01-02-21 |
Michel Revel
FOU | Founder | 85 | 06-10-08 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 14-06-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 17-12-20 | |
Tamar Galili
BRD | Director/Board Member | 51 | 03-01-22 |
Ronen Twito
CHM | Chairman | 49 | 23-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,53% | 103 mld. | |
+3,51% | 96,73 mld. | |
+1,48% | 21,31 mld. | |
-15,65% | 21,21 mld. | |
-6,26% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-21,61% | 13,68 mld. | |
+6,75% | 13,44 mld. | |
+23,86% | 10,98 mld. |